ProfileGDS4459 / ENSG00000107036
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 83% 80% 84% 69% 81% 80% 77% 85% 83% 77% 84% 81% 80% 76% 81% 72% 83% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 16.2683
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.980
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.5884
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.2269
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.2381
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 66.0780
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.9377
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.6785
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 96.5283
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.8877
GSM623474group B, liver allograft wedge biopsie placebo treatment 16.5384
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.3581
GSM623476group B, liver allograft wedge biopsie placebo treatment 36.1180
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.5276
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.3581
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.3272
GSM623480group B, liver allograft wedge biopsie placebo treatment 76.2683